首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Safety Evaluation of Chinese Medicine Injections with a Cell Imaging-Based Multiparametric Assay Revealed a Critical Involvement of Mitochondrial Function in Hepatotoxicity
【2h】

Safety Evaluation of Chinese Medicine Injections with a Cell Imaging-Based Multiparametric Assay Revealed a Critical Involvement of Mitochondrial Function in Hepatotoxicity

机译:基于细胞成像的多参数分析中药注射剂的安全性评估揭示了线粒体功能在肝毒性中的关键作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The safety of herbal medicine products has been a widespread concern due to their complex chemical nature and lack of proper evaluation methods. We have adapted a sensitive and reproducible multiparametric cell-based high-content analysis assay to evaluate the hepatic-safety of four Chinese medicine injections and validated it with classical animal-based toxicity assays. Our results suggested that the reported hepatotoxicity by one of the drugs, Fufangkushen injection, could be attributed at least in part to the interference of mitochondrial function in human HepG2 cells by some of its constituents. This method should be useful for both preclinical screen in a drug discovery program and postclinical evaluation of herbal medicine preparations.
机译:由于其复杂的化学性质和缺乏适当的评估方法,草药产品的安全性已引起广泛关注。我们改编了一种灵敏且可重现的基于多参数细胞的高含量分析方法,以评估四种中药注射剂的肝安全性,并通过基于经典动物的毒性分析法对其进行了验证。我们的研究结果表明,其中一种药物复方苦参注射液的肝毒性据报道至少可以部分归因于其某些成分对人HepG2细胞线粒体功能的干扰。该方法对于药物发现程序中的临床前筛查和草药制剂的临床后评估均应有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号